Category

• Events1
• Pipeline1

Organizations

• Bausch + Lomb61
• Eyes On Eyecare41
• Alcon, Inc.38
• American Optometric Association34
• Harrow26
• Glaukos25
• Aldeyra Therapeutics20
• Regeneron19
• American Academy Of Ophthalmology18
• Coopervision18

Tags

• Cell Therapy2
• Clinical Trials2
• Cornea2
• Ophthalmology Tech Forum1
• Corneal Transplant1
• Genetic Testing1
• Inherited Retinal Disease1
• Ophthalmic Tech1
• Ophthalmology1
• Retina1

• Organizations: Emmetrope Ophthalmics (Emmecell)✕

Clear all

Events

KOLs eye the future of genetic engineering and cell transplantation

Industry leaders from four leading ophthalmic companies debut the latest clinical developments in cell-based therapeutics.

Pipeline

Cell therapy dosing concludes for Emmecell's corneal edema trial

Minimally-invasive cell therapy has been designed to repopulate dysfunctional corneal endothelial cells, potentially eliminating the need for transplantation.